B‐lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays

Self-tolerance is achieved by deleting or regulating self-reactive lymphocytes at a series of cellular checkpoints placed at many points along the developmental pathways to plasma cells and effector T cells. At each checkpoint, what are the molecular pathways that determine whether a lymphocyte remains quiescent, begins dividing, differentiates or dies? In splenic B cells, the decision between quiescence, tolerance by anergy, and activation provides a tractable setting to explore these issues by global gene expression profiling on DNA microarrays. Here we discuss the application of microarrays to illuminate a set of cell fate decisions that appear to be determined by summation of numerous small changes in expression of stimulatory and inhibitory genes. Many genes with known or predicted inhibitory functions are highly expressed in naive, quiescent B cells, notably the signal inhibitor SLAP and DNA-binding proteins of the Kruppel family (LKLF, BKLF, GKLF), Tsc-22, GILZ, Id-3, and GADD45. Activation of naive B cells, triggered by acute binding of antigen to the B-cell receptor, involves a rapid decrease in expression of these inhibitory genes. Promitotic genes are induced in parallel, including c myc, LSIRF/IRF4, cyclin D2, Egr-1 and Egr-2, as are the anti-apoptotic gene A1 and genes for the T-cell-attracting chemokines MIP-1alpha and beta. B-cell tolerance through the process of anergy, induced by chronic binding of self antigen, maintains expression of the inhibitory genes found in quiescent B cells and induces an additional set of inhibitory genes. The latter include inhibitors of signaling - CD72, neurogranin, pcp4 - and additional inhibitors of gene expression such as SATB1, MEF2C, TGIF and Nab-2. The effects of tolerance, the immunosuppressive drug FK506 and other modulators of calcium or MAPK signaling allow individual gene responses to be linked to different signal transduction pathways. The global molecular profiles obtained illustrate how quiescence and anergy are actively maintained in circulating B cells, how these states are switched to clonal expansion and how they could be better emulated by pro-tolerogenic drugs.

[1]  M. Gobbi,et al.  Phorbol ester induces abnormal chronic lymphocytic leukemia cells to express features of hairy cell leukemia. , 1985, Blood.

[2]  K. Wüthrich,et al.  Structure comparison of human glioma pathogenesis-related protein GliPR and the plant pathogenesis-related protein P14a indicates a functional link between the human immune system and a plant defense system. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  G. Gerton,et al.  Autoantigen 1 of the guinea pig sperm acrosome is the homologue of mouse Tpx‐1 and human TPX1 and is a member of the cysteine‐rich secretory protein (CRISP) family , 1996, Molecular reproduction and development.

[4]  C. Goodnow,et al.  IgD expression on B cells is more efficient than IgM but both receptors are functionally equivalent in up‐regulation CD80/CD86 co‐stimulatory molecules , 1995, European journal of immunology.

[5]  T. Buttke,et al.  Stearoyl-CoA desaturase gene expression in lymphocytes. , 1992, Biochemical and biophysical research communications.

[6]  R. Schwartz,et al.  Effects of cyclosporine A on T cell development and clonal deletion. , 1988, Science.

[7]  A. Strasser,et al.  B Lymphocytes Differentially Use the Rel and Nuclear Factor κB1 (NF-κB1) Transcription Factors to Regulate Cell Cycle Progression and Apoptosis in Quiescent and Mitogen-activated Cells , 1998, The Journal of experimental medicine.

[8]  M. Snoek,et al.  A novel gene, G7e, resembling a viral envelope gene, is located at the recombinational hot spot in the class III region of the mouse MHC. , 1996, Genomics.

[9]  K. Rajewsky,et al.  Mature Follicular Dendritic Cell Networks Depend on Expression of Lymphotoxin β Receptor by Radioresistant Stromal Cells and of Lymphotoxin β and Tumor Necrosis Factor by B Cells , 1999, The Journal of experimental medicine.

[10]  E. Wagner,et al.  Mice lacking c-fos have normal hematopoietic stem cells but exhibit altered B-cell differentiation due to an impaired bone marrow environment , 1994, Molecular and cellular biology.

[11]  J. Massagué,et al.  A Smad Transcriptional Corepressor , 1999, Cell.

[12]  J. Lupski,et al.  Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies. , 1999, Human molecular genetics.

[13]  K. Miyake,et al.  RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. , 1995, Journal of immunology.

[14]  A. Foussat,et al.  Antigen Receptor Engagement Selectively Induces Macrophage Inflammatory Protein-1α (MIP-1α) and MIP-1β Chemokine Production in Human B Cells , 1999, The Journal of Immunology.

[15]  J. Norton,et al.  Distinct mechanisms for rescue from apoptosis in Ramos human B cells by signaling through CD40 and interleukin‐4 receptor: role for inhibition of an early response gene, Berg36 , 1996, European journal of immunology.

[16]  F. Chan,et al.  Functional redundancy of the Nur77 and Nor‐1 orphan steroid receptors in T‐cell apoptosis , 1997, The EMBO journal.

[17]  E. Shaoul,et al.  Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. , 1999, Blood.

[18]  J. Kaye,et al.  Induction of the Early Growth Response (Egr) Family of Transcription Factors during Thymic Selection , 1997, The Journal of experimental medicine.

[19]  P. Blackshear,et al.  Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. , 1998, Science.

[20]  M E Greenberg,et al.  Neuronal activity-dependent cell survival mediated by transcription factor MEF2. , 1999, Science.

[21]  F. Blattner,et al.  The molecular biology of immunoglobulin D , 1984, Nature.

[22]  K. Willison,et al.  The Chaperonin Containing TCP-1 (CCT). Displays a Single-Ring Mediated Disassembly and Reassembly Cycle , 1998, Biological chemistry.

[23]  A. Sher,et al.  Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. , 1997, Immunity.

[24]  N. Copeland,et al.  Evi-2, a common integration site involved in murine myeloid leukemogenesis , 1990, Molecular and cellular biology.

[25]  A. Aderem,et al.  Identification of the basolateral targeting determinant of a peripheral membrane protein, MacMARCKS, in polarized cells , 1998, Current Biology.

[26]  C. Goodnow,et al.  Growing up on the streets: why B-cell development differs from T-cell development. , 1999, Immunology today.

[27]  A. Strasser,et al.  Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. , 1995, Genes & development.

[28]  Jeffrey Crosbie,et al.  Induction of self-tolerance in mature peripheral B lymphocytes , 1989, Nature.

[29]  Tsonwin Hai,et al.  ATF3 and stress responses. , 1999, Gene expression.

[30]  J. Leiden,et al.  LKLF: A transcriptional regulator of single-positive T cell quiescence and survival. , 1997, Science.

[31]  D. Gilbert,et al.  Mcm2, but Not Rpa, Is a Component of the Mammalian Early G1-Phase Prereplication Complex , 1999, The Journal of cell biology.

[32]  Christopher C. Goodnow,et al.  How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis , 2000, Nature.

[33]  L. Glimcher,et al.  Sequential involvement of NFAT and Egr transcription factors in FasL regulation. , 2000, Immunity.

[34]  W. Paul,et al.  Frequency of B lymphocytes responsive to anti-immunoglobulin , 1982, The Journal of experimental medicine.

[35]  F. Berberich-Siebelt,et al.  A1 expression is stimulated by CD40 in B cells and rescues WEHI 231 cells from anti‐IgM‐induced cell death , 1999, European journal of immunology.

[36]  B. Klein,et al.  Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma , 1997, Nature Genetics.

[37]  G. Lipowsky,et al.  CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2 , 1996, Molecular and cellular biology.

[38]  L. Wodicka,et al.  Genome-wide expression monitoring in Saccharomyces cerevisiae , 1997, Nature Biotechnology.

[39]  T. Tokuhisa,et al.  mel-18 negatively regulates cell cycle progression upon B cell antigen receptor stimulation through a cascade leading to c-myc/cdc25. , 1998, Immunity.

[40]  S. Garel,et al.  Nab proteins mediate a negative feedback loop controlling Krox-20 activity in the developing hindbrain. , 2000, Development.

[41]  G. Crabtree,et al.  Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. , 1997, Immunity.

[42]  A. W. Harris,et al.  The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice , 1986, Cell.

[43]  M. Koshland,et al.  Myocyte Enhancer Factor-related B-MEF2 Is Developmentally Expressed in B Cells and Regulates the Immunoglobulin J Chain Promoter* , 1998, The Journal of Biological Chemistry.

[44]  P. Cresswell,et al.  Intracellular formation and cell surface expression of a complex of an intact lysosomal protein and MHC class II molecules. , 1998, Journal of immunology.

[45]  Achim Leutz,et al.  A C/EBPβ Isoform Recruits the SWI/SNF Complex to Activate Myeloid Genes , 1999 .

[46]  M. Reth,et al.  The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. , 1998, Journal of immunology.

[47]  Mark M. Davis,et al.  CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+T cells , 1995, Nature.

[48]  B. Sefton,et al.  Association between B-lymphocyte membrane immunoglobulin and multiple members of the Src family of protein tyrosine kinases , 1992, Molecular and cellular biology.

[49]  M. Jackson,et al.  Gene expression profiles of laser-captured adjacent neuronal subtypes , 1999, Nature Medicine.

[50]  C. Ware,et al.  Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Andrius Kazlauskas,et al.  Diverse Signaling Pathways Activated by Growth Factor Receptors Induce Broadly Overlapping, Rather Than Independent, Sets of Genes , 1999, Cell.

[52]  K. Rajewsky,et al.  In Vivo Ablation of Surface Immunoglobulin on Mature B Cells by Inducible Gene Targeting Results in Rapid Cell Death , 1997, Cell.

[53]  J. McDermott,et al.  The C. elegans gene pag-3 is homologous to the zinc finger proto-oncogene gfi-1. , 1997, Development.

[54]  P. O'Connell,et al.  Identification and characterization of transcripts from the neurofibromatosis 1 region: the sequence and genomic structure of EVI2 and mapping of other transcripts. , 1990, Genomics.

[55]  Hilmar Bading,et al.  Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression , 1997, Nature.

[56]  R. Eisenman,et al.  c-Myc enhances protein synthesis and cell size during B lymphocyte development. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[57]  C. Goodnow,et al.  Abortive Proliferation of Rare T Cells Induced by Direct or Indirect Antigen Presentation by Rare B Cells In Vivo , 1998, The Journal of experimental medicine.

[58]  Kathleen Kelly,et al.  Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1 , 1994, Nature.

[59]  T. Perneger.  What's wrong with Bonferroni adjustments , 1998, BMJ.

[60]  K. Rajewsky,et al.  Immunoglobulin D (IgD)-deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells , 1993, The Journal of experimental medicine.

[61]  A. Aderem,et al.  MacMARCKS Is Not Essential for Phagocytosis in Macrophages* , 1998, The Journal of Biological Chemistry.

[62]  T. Wirth,et al.  Identification of CD36 as the first gene dependent on the B-cell differentiation factor Oct-2. , 1995, Genes & development.

[63]  M. Roussel,et al.  Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. , 1999, Genes & development.

[64]  C. Moratz,et al.  Regulator of G Protein Signaling 1 (RGS1) Markedly Impairs Giα Signaling Responses of B Lymphocytes , 2000, The Journal of Immunology.

[65]  Ronald W. Davis,et al.  Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.

[66]  M. Ginsberg,et al.  Class- and Splice Variant-specific Association of CD98 with Integrin β Cytoplasmic Domains* , 2000, The Journal of Biological Chemistry.

[67]  Wei Wei Wu,et al.  Induction of cell cycle regulatory proteins in anti-immunoglobulin- stimulated mature B lymphocytes , 1996, The Journal of experimental medicine.

[68]  S. Brown,et al.  The herpes simplex virus virulence factor ICP34.5 and the cellular protein MyD116 complex with proliferating cell nuclear antigen through the 63-amino-acid domain conserved in ICP34.5, MyD116, and GADD34 , 1997, Journal of virology.

[69]  P. Linsley,et al.  Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells , 1994, The Journal of experimental medicine.

[70]  D. Mason,et al.  Development and follicular localization of tolerant B lymphocytes in lysozyme/anti-lysozyme IgM/IgD transgenic mice. , 1992, International immunology.

[71]  A. Mantovani,et al.  Bacterial lipopolysaccharide causes rapid shedding, followed by inhibition of mRNA expression, of the IL-1 type II receptor, with concomitant up-regulation of the type I receptor and induction of incompletely spliced transcripts. , 1999, Journal of immunology.

[72]  J. V. van Mourik,et al.  Small GTP‐binding proteins in human endothelial cells , 1998, British journal of haematology.

[73]  C. Goodnow,et al.  A selective defect in IgM antigen receptor synthesis and transport causes loss of cell surface IgM expression on tolerant B lymphocytes. , 1994, The EMBO journal.

[74]  J. Cyster,et al.  Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. , 1998, Immunity.

[75]  J. D. Engel,et al.  Perinatal synthetic lethality and hematopoietic defects in compound mafG::mafK mutant mice , 2000, The EMBO journal.

[76]  B. Black,et al.  Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. , 1998, Annual review of cell and developmental biology.

[77]  T. Mak,et al.  Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45 , 1996, Nature.

[78]  A. Gottschalk,et al.  Fc gamma RII cross-linking inhibits anti-Ig-induced erg-1 and erg-2 expression in BCL1. , 1994, Journal of immunology.

[79]  M. Cooke,et al.  Self-tolerance checkpoints in B lymphocyte development. , 1995, Advances in immunology.

[80]  J. Eberwine,et al.  Amplified RNA synthesized from limited quantities of heterogeneous cDNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[81]  M. Wright.  Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. , 1996, Human & experimental toxicology.

[82]  H. Youn,et al.  Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. , 1999, Science.

[83]  S. Inoue,et al.  Underdeveloped uterus and reduced estrogen responsiveness in mice with disruption of the estrogen-responsive finger protein gene, which is a direct target of estrogen receptor alpha. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[84]  M. Moskowitz,et al.  Defects in regulation of apoptosis in caspase-2-deficient mice. , 1998, Genes & development.

[85]  M. Crossley,et al.  Basic Krüppel-like factor functions within a network of interacting haematopoietic transcription factors. , 1999, The international journal of biochemistry & cell biology.

[86]  C. Shoemaker,et al.  Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family , 1998, Nature.

[87]  E. Butcher,et al.  Regulation of Chemotactic and Proadhesive Responses to Chemoattractant Receptors by RGS (Regulator of G-protein Signaling) Family Members* , 1998, The Journal of Biological Chemistry.

[88]  K. Dellagi,et al.  Vimentin gene: expression in human lymphocytes and in Burkitt's lymphoma cells. , 1986, The EMBO journal.

[89]  M. Levine,et al.  Interaction of short-range repressors with Drosophila CtBP in the embryo. , 1998, Science.

[90]  Anthony C. Bishop,et al.  Entry of B Cell Receptor into Signaling Domains Is Inhibited in Tolerant B Cells , 2000, The Journal of experimental medicine.

[91]  J. Milbrandt,et al.  Unimpaired macrophage differentiation and activation in mice lacking the zinc finger transplantation factor NGFI-A (EGR1) , 1996, Molecular and cellular biology.

[92]  R. Dolmetsch,et al.  Quantitative and qualitative control of antigen receptor signalling in tolerant B lymphocytes. , 1998, Novartis Foundation symposium.

[93]  D. Carrasco,et al.  Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. , 1996, Oncogene.

[94]  J. Norton,et al.  B cell early response gene expression coupled to B cell receptor, CD40 and interleukin‐4 receptor co‐stimulation: evidence for a role of the egr‐2/krox20 transcription factor in B cell proliferation , 1996, European journal of immunology.

[95]  Hong Sun,et al.  Stra13 expression is associated with growth arrest and represses transcription through histone deacetylase (HDAC)-dependent and HDAC-independent mechanisms. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[96]  J. Sprent,et al.  Abnormal differentiation of thymocytes in mice treated with cyclosporin A , 1988, Nature.

[97]  Jiahuai Han,et al.  Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation , 1997, Nature.

[98]  L. Curtiss,et al.  Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In. , 1986, Journal of immunology.

[99]  J. Milbrandt,et al.  Novel mutants of NAB corepressors enhance activation by Egr transactivators , 1998, The EMBO journal.

[100]  C. Gilks,et al.  The Gfi-1 protooncoprotein represses Bax expression and inhibits T-cell death. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[101]  T. Miyazaki.  Two Distinct Steps during Thymocyte Maturation from CD4−CD8− to CD4+CD8+ Distinguished in the Early Growth Response (Egr)-1 Transgenic Mice with a Recombinase-activating Gene–Deficient Background , 1997, The Journal of experimental medicine.

[102]  P. Zipfel,et al.  The Transcription Factor Early Growth Response 1 (Egr-1) Advances Differentiation of Pre-B and Immature B Cells , 1998, The Journal of experimental medicine.

[103]  T. Mak,et al.  Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function , 1997, Science.

[104]  M. Cole,et al.  c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets. , 1998, Genes & development.

[105]  J. Frederick,et al.  Impaired Immune Responses and B-Cell Proliferation in Mice Lacking the Id3 Gene , 1999, Molecular and Cellular Biology.

[106]  A. Cardin,et al.  Suppression of lymphocyte activation by plasma lipoproteins. , 1983, Cancer research.

[107]  K. Calame,et al.  Transcriptional Repression by Blimp-1 (PRDI-BF1) Involves Recruitment of Histone Deacetylase , 2000, Molecular and Cellular Biology.

[108]  Beni M. Sahai,et al.  Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes , 1989, Nature.

[109]  K. Preissner,et al.  Urokinase Receptor (CD87) Regulates Leukocyte Recruitment via β2 Integrins In Vivo , 1998, The Journal of experimental medicine.

[110]  N. Baumgarth,et al.  CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation. , 1999, Immunity.

[111]  A. Pandey,et al.  Src-like Adaptor Protein (Slap) Is a Negative Regulator of T Cell Receptor Signaling , 2000, The Journal of experimental medicine.

[112]  C. Preudhomme,et al.  Genomic structure and assignment of the RhoH/TTF small GTPase gene (ARHH) to 4p13 by in situ hybridization. , 1997, Genomics.

[113]  G. Prud’homme,et al.  Cyclosporine, tolerance, and autoimmunity. , 1993, Clinical immunology and immunopathology.

[114]  C. Goodnow,et al.  Breakdown of self-tolerance in anergic B lymphocytes , 1991, Nature.

[115]  K. Rock,et al.  TAP transcription and phosphatidylinositol linkage mutants are defective in activation through the T cell receptor , 1988, Cell.

[116]  J. Yewdell,et al.  Gem: an induced, immediate early protein belonging to the Ras family. , 1994, Science.

[117]  Christopher C. Goodnow,et al.  Differential activation of transcription factors induced by Ca2+ response amplitude and duration , 1997, Nature.

[118]  T. Yamagata,et al.  ICSAT overexpression is not sufficient to cause adult T-cell leukemia or multiple myeloma. , 1999, Biochemical and biophysical research communications.

[119]  R. Koski,et al.  Synthesis, degradation, and subcellular localization of proteins encoded by the primary response genes TIS7/PC4 and TIS21/PC3 , 1994, Journal of cellular physiology.

[120]  D. Cook.  Requirement of MIP-1α for an inflammatory response to viral infection , 1995 .

[121]  S. Gerondakis,et al.  Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. , 1999, Genes & development.

[122]  J. den Hertog,et al.  Transforming growth factor-beta-stimulated clone-22 is a member of a family of leucine zipper proteins that can homo- and heterodimerize and has transcriptional repressor activity. , 1999, The Journal of biological chemistry.

[123]  D. Lockhart,et al.  Expression monitoring by hybridization to high-density oligonucleotide arrays , 1996, Nature Biotechnology.

[124]  U. Staubli,et al.  The polo‐like protein kinases Fnk and Snk associate with a Ca2+‐ and integrin‐binding protein and are regulated dynamically with synaptic plasticity , 1999, The EMBO journal.

[125]  E. Kieff,et al.  Characterization of an Epstein-Barr virus receptor on human epithelial cells , 1992, The Journal of experimental medicine.

[126]  R. Flavell,et al.  Expansion or Elimination of B Cells In Vivo: Dual Roles for CD40- and Fas (CD95)-Ligands Modulated by the B Cell Antigen Receptor , 1996, Cell.

[127]  S. Fullerton,et al.  Camstatins Are Peptide Antagonists of Calmodulin Based Upon a Conserved Structural Motif in PEP-19, Neurogranin, and Neuromodulin* , 1996, The Journal of Biological Chemistry.

[128]  Liangji Zhou,et al.  A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. , 1992, Journal of immunology.

[129]  H. Dintzis,et al.  The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence. , 1989, Journal of immunology.

[130]  Elaine Fuchs,et al.  Klf4 is a transcription factor required for establishing the barrier function of the skin , 1999, Nature Genetics.

[131]  U. Weidle,et al.  Control of cell growth by c-Myc in the absence of cell division , 1999, Current Biology.

[132]  David E. Levy,et al.  STAT1 Affects Lymphocyte Survival and Proliferation Partially Independent of Its Role Downstream of IFN-γ1 , 2000, The Journal of Immunology.

[133]  J. Cyster,et al.  Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. , 1995, Immunity.

[134]  K. Meyer,et al.  Repression of the immunoglobulin heavy chain 3′ enhancer by helix‐loop‐helix protein Id3 via a functionally important E47/E12 binding site: implications for developmental control of enhancer function , 1995, European journal of immunology.

[135]  P. Lichter,et al.  Spleen-specific Expression of the Malaria-inducible Intronless Mouse Gene imap38 * , 1999, The Journal of Biological Chemistry.

[136]  William F. Morgan,et al.  Genomic instability in Gadd45a-deficient mice , 1999, Nature Genetics.

[137]  J. Cloutier,et al.  Cooperative Inhibition of  T-Cell Antigen Receptor Signaling by a Complex between a Kinase and a Phosphatase , 1999, The Journal of experimental medicine.

[138]  P. Stanley,et al.  Mice lacking N-acetylglucosaminyltransferase I activity die at mid-gestation, revealing an essential role for complex or hybrid N-linked carbohydrates. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[139]  H. Zinszner,et al.  Identification of novel stress‐induced genes downstream of chop , 1998, The EMBO journal.

[140]  W. Zong,et al.  The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis , 1999 .

[141]  M. Gold,et al.  Examination of B lymphoid cell lines for membrane immunoglobulin-stimulated tyrosine phosphorylation and src-family tyrosine kinase mRNA expression. , 1992, Molecular immunology.

[142]  Thorsten Schmidt,et al.  Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis , 1998, Oncogene.

[143]  V. Sukhatme,et al.  Methylation of an immediate-early inducible gene as a mechanism for B cell tolerance induction. , 1990, Science.